EIPM's 1Q 2025 External Newsletter
April 3, 2025
EIPM's First Quarter 2025 External NewsletterMemo
March 31, 2025
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our first quarterly external newsletter of 2025!
April 2025 EIPM Director's Memo
April 3, 2025
April 2025 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
AI Meets Oncology: New Model Personalizes Bladder Cancer Treatment
March 30, 2025
Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging and gene expression analyses in a way that outperforms previous models using a single data type.
EIPM Researcher Explores “Bioenergetic Age” link to Alzheimer’s
March 19, 2025
A person’s “bioenergetic age” – or how youthfully their cells generate energy – might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
The study, published Feb. 24 in Nature Communications, suggests healthy living can turn back the bioenergetic clock for some people, helping them fend off Alzheimer’s as effectively as a new drug called lecanemab.
Lowering Bioenergetic Age May Help Fend Off Alzheimer’s
March 13, 2025
A person’s bioenergetic clock ticks forward based on genetics, but having a healthy lifestyle—such as eating a plant-based diet and exercising—may help keep Alzheimer's symptoms at bay. Credit: Shutterstock
‘Flipping’ switch boosts stem cell numbers for therapies
March 12, 2025
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators. The discovery could lead to more effective bone marrow transplants and gene therapies.
Islet Transplantation with Blood Vessel Cells Shows Promise to Treat Type 1 Diabetes
February 22, 2025
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators. The new approach, which requires further development and testing, could someday enable the much wider use of islet transplants to cure diabetes.
Two EIPM Faculty Members Elected to ASCI
February 12, 2025
Two Weill Cornell Medicine physician-scientists, Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani, have been elected members of the American Society for Clinical Investigation (ASCI) for 2025.
Mapping of Specialized Blood Vessel Cells May Lead to Diabetes Treatments
February 8, 2025
The distinct population of endothelial cells that line blood vessels in the insulin-producing “islets” of the human pancreas have been notoriously difficult to study, but Weill Cornell Medicine investigators have now succeeded in comprehensively detailing the unique characteristics of these cells. The resulting atlas advances basic research on the biology of the pancreas and could lead to new treatment strategies for diabetes and other pancreatic diseases.